Overview
- 93 inspections across 79 sites are on record.
- 208 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-18.
At a glance
Inspections
93
Sites
79
Observations
208
Career since
Oct 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fresenius Kabi USA LLC | 18 Feb 2026 | Human Drugs | On file |
| Eurofins EAG Materials Science, LLC | 11 Dec 2025 | Human Drugs | On file |
| Olon USA LLC | 10 Oct 2025 | Human Drugs | |
| DDP Specialty Electronic Materials US 9, LLC | 16 Apr 2025 | Human Drugs | |
| Novartis Manufacturing LLC | 4 Mar 2025 | Human Drugs | On file |
Sites inspected
Fresenius Kabi USA LLCMelrose Park, United States1 insp.
Eurofins EAG Materials Science, LLCMaryland Heights, United States1 insp.
Olon USA LLCConcord Township, United States1 insp.
DDP Specialty Electronic Materials US 9, LLCHemlock, United States1 insp.
Novartis Manufacturing LLCIndianapolis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ucheabuchi C Chudi-Nwankwor9 shared
Keith J Mason8 shared
Michael E Campbell5 shared
Javonica F Penn5 shared
Nicholas L Paulin3 shared
Michael D Thatcher3 shared
Joohi Castelvetere2 shared
Supreet K Sran2 shared
Nicholas J Presto2 shared
Vaishali J Patel2 shared
Full investigator report
Get the verbatim findings behind Andrew J Barrowcliff's 208 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site